Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season
NCT03688620
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1060
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza, Human
Interventions
OTHER:
Passive enhanced safety surveillance
Sponsor
GlaxoSmithKline